Related Experiment Video

Updated: Aug 6, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin

Baoli Hu1, Daniele M Gilkes, Bilal Farooqi

  • 1Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

The Journal of Biological Chemistry
|August 15, 2006
PubMed

Insights

The tumor suppressor p53 is crucial for genomic stability. While MDM2 inhibitors like Nutlin 3 activate p53, MDMX can block this. Targeting MDMX alongside MDM2 may enhance p53 activation in cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The p53 tumor suppressor is vital for preventing cancer by maintaining genomic stability.
  • MDM2 and MDMX are key negative regulators of p53 stability and activity.
  • MDM2 inhibitors, such as Nutlin 3, have been developed to reactivate p53.

Purpose of the Study:

  • To investigate the role of MDMX in modulating p53 activity in response to MDM2 inhibition.
  • To assess the potential of targeting MDMX as a therapeutic strategy for cancer.

Main Methods:

  • Utilized Nutlin 3, an MDM2 inhibitor, to study p53-MDM2 and p53-MDMX interactions.
  • Employed MDMX siRNA to reduce MDMX expression in tumor cells.
  • Assessed p53 activation and cellular growth arrest.

Main Results:

  • Nutlin 3 effectively inhibits p53-MDM2 binding but does not disrupt p53-MDMX interaction.
  • Overexpression of MDMX compromises Nutlin 3-induced p53 activation.
  • Combined Nutlin 3 treatment with MDMX siRNA leads to synergistic p53 activation and growth arrest.

Conclusions:

  • MDMX is a significant factor limiting the efficacy of MDM2 inhibitors in certain cancers.
  • MDMX represents a viable therapeutic target for p53 activation in tumors.
  • Development of MDMX-specific or dual MDM2/MDMX inhibitors is warranted for complete p53 reactivation.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...